<DOC>
	<DOCNO>NCT00823901</DOCNO>
	<brief_summary>The purpose study determine whether Clindamycin Phosphate 1.2 % And Tretinoin 0.025 % Gel effective safe treatment papulopustular rosacea .</brief_summary>
	<brief_title>Safety Efficacy Study Clindamycin Phosphate 1.2 % Tretinoin 0.025 % Gel Treat Rosacea</brief_title>
	<detailed_description>Currently , know cure rosacea . The effective treatment systemic antibiotic , particularly tetracycline family . Topical treatment include metronidazole , antibacterial erythromycin clindamycin , sulfacetamide benzoyl peroxide . Isotretinoin ( Accutane ) also use .</detailed_description>
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>1 . Subjects 18 year age old . 2 . Clinical diagnosis papulopustular facial rosacea . 3 . A minimum 4 50 facial inflammatory lesion ( papule plus pustule ) . 4 . Willing able understand sign inform consent . 5 . Able complete study comply study procedure . 1 . Acne conglobata , acne fulminans , secondary acne ( chloracne , druginduced acne , etc . ) , severe acne require systemic treatment . 2 . History presence regional enteritis inflammatory bowel disease ( e.g. , ulcerative colitis , pseudomembranous colitis , chronic diarrhea , history antibioticassociated colitis , bloody diarrhea ) similar symptom . 3 . Use topical rosacea treatment past 2 week . 4 . Use systemic antibiotic past 4 week . 5 . Use systemic retinoids within past 3 month . 6 . Use laser light base rosacea treatment within past 2 month . 7 . Concomitant use medication report exacerbate rosacea , topical systemic steroid may impact assessment . 8 . Current drug alcohol abuse . 9 . Other dermatologic condition require use interfering topical systemic therapy might interfere study assessment , limited , atopic dermatitis , perioral dermatitis acne vulgaris . 10 . Clinically significant abnormal finding condition ( rosacea ) , might , opinion Investigator , interfere study evaluation pose risk subject safety study . 11 . Subjects pregnant planning pregnancy . 12 . Use investigational therapy within past 4 week . 13 . Known hypersensitivity previous allergic reaction clindamycin retinoids</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>rosacea</keyword>
	<keyword>clindamycin</keyword>
	<keyword>tretinoin</keyword>
	<keyword>clinical study</keyword>
	<keyword>treatment</keyword>
</DOC>